- Conditions
- Coronary Artery Disease
- Interventions
- CYPHER Sirolimus-eluting Coronary Stent
- Device
- Lead sponsor
- Cordis US Corp.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2009
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Coronary Occlusions
- Interventions
- Cypher sirolimus eluting coronary stent
- Device
- Lead sponsor
- Sunil Rao
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2012
- U.S. locations
- 13
- States / cities
- La Jolla, California • Washington D.C., District of Columbia • Atlanta, Georgia + 8 more
- Conditions
- Coronary Artery Disease
- Interventions
- Immediate disclosure of CAD PRS results, Deferred Disclosure of CAD PRS results
- Behavioral
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 30 Years to 75 Years
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Myocardial Infarction
- Interventions
- OCT, CMR
- Device · Other
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 21 Years to 99 Years
- Enrollment
- 450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2027
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Los Angeles, California • San Diego, California + 11 more
- Conditions
- HIV/AIDS, Myocardial Infarction
- Interventions
- Cardiac PET, 99mTc-tilmanocept SPECT/CT, Contrast Enhanced Coronary and Aortic Computed Tomography Angiography
- Radiation
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 40 Years to 79 Years · Female only
- Enrollment
- 62 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Myocardial Ischemia, Coronary Artery Disease, Arteriosclerosis, Chronic Stable Angina
- Interventions
- Ranolazine, Placebo
- Drug
- Lead sponsor
- East Carolina University
- Other
- Eligibility
- 21 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Greenville, North Carolina
- Conditions
- Ischemic Heart Disease, Myocardial Ischemia
- Interventions
- Not listed
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- NIH
- Eligibility
- Not listed
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2002
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Coronary Artery Disease
- Interventions
- Coronary Artery Bypass
- Procedure
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 87 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Arterial Occlusion, Cardiovascular Diseases, Atherosclerosis, Hematoma, Anticoagulant-induced Bleeding, Coronary Artery Disease
- Interventions
- Statseal with TR Band, TR band only
- Device
- Lead sponsor
- VA Long Beach Healthcare System
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 443 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Long Beach, California
- Conditions
- Type 2 Diabetes, Coronary Artery Disease
- Interventions
- Semaglutide 2 MG/1.5 ML Subcutaneous Solution, Placebo
- Drug
- Lead sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Torrance, California
- Conditions
- Psoriasis, Metabolic Syndrome, Hyperlipidemia, Obesity, Hypertension
- Interventions
- Etanercept
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2013
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Coronary Artery Disease
- Interventions
- Resolute Zotarolimus-Eluting Coronary Stent
- Device
- Lead sponsor
- Medtronic Vascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,516 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2016
- U.S. locations
- 1
- States / cities
- Tyler, Texas
- Conditions
- Angina, Non-obstructive Coronary Artery Disease
- Interventions
- PET imaging, Coronary CT angiogram, Functional Angiography, Treadmill exercise stress study
- Radiation · Procedure
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Acute Myocardial Infarction, STEMI
- Interventions
- FDY-5301, Placebo
- Drug · Other
- Lead sponsor
- Faraday Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 2
- States / cities
- Minneapolis, Minnesota • The Bronx, New York
- Conditions
- Coronary Artery Disease
- Interventions
- Decision Aid, CAD Education
- Behavioral
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 677 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 4
- States / cities
- San Francisco, California • Atlanta, Georgia • Kansas City, Missouri
- Conditions
- Coronary Artery Disease
- Interventions
- Not listed
- Lead sponsor
- Saint Luke's Health System
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 750 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 21
- States / cities
- Phoenix, Arizona • San Diego, California • Washington D.C., District of Columbia + 15 more
- Conditions
- Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Atherosclerosis, Arterial Inflammation, Vascular Diseases, Vascular Disease, Peripheral, Vascular Calcification, High Cholesterol/Hyperlipidemia, Heart Diseases, Heart Attack, Stroke, Cerebrovascular Accident, Carotid Artery Diseases, Carotid Atherosclerosis, Transient Ischemic Attack
- Interventions
- 99mTc-tilmanocept SPECT/CT scanning
- Other
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years to 85 Years
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Coronary Stenoses, Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease, Coronary Occlusion
- Interventions
- Not listed
- Lead sponsor
- Ochsner Health System
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Acute Coronary Syndrome
- Interventions
- vicagrel Capsules, Clopidogrel Tablets
- Drug
- Lead sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 128 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Kansas City, Missouri
- Conditions
- STEMI, STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction (MI), Stent Implantation
- Interventions
- Atibuclimab (IC14), 20 mg/kg intravenously, once, Placebo, 150 mL intravenously, once
- Drug · Other
- Lead sponsor
- Implicit Bioscience
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 2
- States / cities
- St Louis, Missouri • Charlottesville, Virginia
- Conditions
- Acute Coronary Syndrome
- Interventions
- Lixisenatide (AVE0010), Placebo
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 6,068 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2015
- U.S. locations
- 200
- States / cities
- Birmingham, Alabama • Foley, Alabama • Mobile, Alabama + 160 more
- Conditions
- Cardiovascular Disease, Acute Coronary Syndrome
- Interventions
- Multifaceted Intervention with pharmacist and IVR
- Other
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years to 91 Years
- Enrollment
- 14,573 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2022
- U.S. locations
- 15
- States / cities
- Aurora, Colorado • Washington D.C., District of Columbia • Gainesville, Florida + 12 more
- Conditions
- Diabetes, Hypertension, Dyslipidemia, Coronary Arteriosclerosis
- Interventions
- Behavioral counseling and peer support, Interactive Education, Role modeling, Pharmacologic case management
- Behavioral · Procedure
- Lead sponsor
- Providence VA Medical Center
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 118 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2008
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- Hypercholesterolemia
- Interventions
- PRO-040201, Placebo
- Drug
- Lead sponsor
- Arbutus Biopharma Corporation
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 23 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio